196 related articles for article (PubMed ID: 36405982)
21. Bioresponsive nanomedicines based on dynamic covalent bonds.
Xin X; Zhang Z; Zhang X; Chen J; Lin X; Sun P; Liu X
Nanoscale; 2021 Jul; 13(27):11712-11733. PubMed ID: 34227639
[TBL] [Abstract][Full Text] [Related]
22. Bioinspired Polymeric-based Core-shell Smart Nano-systems.
Harwansh RK; Deshmukh R; Barkat MA; Rahman MA
Pharm Nanotechnol; 2019; 7(3):181-205. PubMed ID: 31486750
[TBL] [Abstract][Full Text] [Related]
23. Engineered bioresponsive nanotherapeutics: recent advances in the treatment of atherosclerosis and ischemic-related disease.
Rumanti AP; Maruf A; Liu H; Ge S; Lei D; Wang G
J Mater Chem B; 2021 Jun; 9(24):4804-4825. PubMed ID: 34085084
[TBL] [Abstract][Full Text] [Related]
24. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
25. Stimuli-Responsive Polymeric Nanoplatforms for Cancer Therapy.
Chang D; Ma Y; Xu X; Xie J; Ju S
Front Bioeng Biotechnol; 2021; 9():707319. PubMed ID: 34249894
[TBL] [Abstract][Full Text] [Related]
26. Recent advances in dual- and multi-responsive nanomedicines for precision cancer therapy.
Zhang Y; Li J; Pu K
Biomaterials; 2022 Dec; 291():121906. PubMed ID: 36395660
[TBL] [Abstract][Full Text] [Related]
27. Cyclodextrin nanosystems in oral drug delivery: A mini review.
Adeoye O; Cabral-Marques H
Int J Pharm; 2017 Oct; 531(2):521-531. PubMed ID: 28455134
[TBL] [Abstract][Full Text] [Related]
28. Combinatorial-designed multifunctional polymeric nanosystems for tumor-targeted therapeutic delivery.
Abeylath SC; Ganta S; Iyer AK; Amiji M
Acc Chem Res; 2011 Oct; 44(10):1009-17. PubMed ID: 21761902
[TBL] [Abstract][Full Text] [Related]
29. Bioresponsive Immunotherapeutic Materials.
Han J; Sheng T; Zhang Y; Cheng H; Gao J; Yu J; Gu Z
Adv Mater; 2023 Jan; ():e2209778. PubMed ID: 36639983
[TBL] [Abstract][Full Text] [Related]
30. Recent Advances in Stimuli-Sensitive Amphiphilic Polymer-Paclitaxel Prodrugs.
Zhou M; Wen L; Wang C; Lei Q; Li Y; Yi X
Front Bioeng Biotechnol; 2022; 10():875034. PubMed ID: 35464718
[TBL] [Abstract][Full Text] [Related]
31. Recent progress in stimuli-responsive nanosystems for inducing immunogenic cell death.
Banstola A; Poudel K; Kim JO; Jeong JH; Yook S
J Control Release; 2021 Sep; 337():505-520. PubMed ID: 34314800
[TBL] [Abstract][Full Text] [Related]
32. Recent Advances in Well-Designed Therapeutic Nanosystems for the Pancreatic Ductal Adenocarcinoma Treatment Dilemma.
Yang XY; Lu YF; Xu JX; Du YZ; Yu RS
Molecules; 2023 Feb; 28(3):. PubMed ID: 36771172
[TBL] [Abstract][Full Text] [Related]
33. Polymeric nanoparticles for targeted treatment in oncology: current insights.
Prabhu RH; Patravale VB; Joshi MD
Int J Nanomedicine; 2015; 10():1001-18. PubMed ID: 25678788
[TBL] [Abstract][Full Text] [Related]
34. Biodegradable Antibacterial Polymeric Nanosystems: A New Hope to Cope with Multidrug-Resistant Bacteria.
Ding X; Wang A; Tong W; Xu FJ
Small; 2019 May; 15(20):e1900999. PubMed ID: 30957927
[TBL] [Abstract][Full Text] [Related]
35. Reduction-sensitive polymeric nanomedicines: An emerging multifunctional platform for targeted cancer therapy.
Sun H; Zhang Y; Zhong Z
Adv Drug Deliv Rev; 2018 Jul; 132():16-32. PubMed ID: 29775625
[TBL] [Abstract][Full Text] [Related]
36. Inhalable bioresponsive chitosan microspheres of doxorubicin and soluble curcumin augmented drug delivery in lung cancer cells.
Jyoti K; Pandey RS; Kush P; Kaushik D; Jain UK; Madan J
Int J Biol Macromol; 2017 May; 98():50-58. PubMed ID: 28130133
[TBL] [Abstract][Full Text] [Related]
37. Advances in mesoporous silica-based nanocarriers for co-delivery and combination therapy against cancer.
Castillo RR; Colilla M; Vallet-Regí M
Expert Opin Drug Deliv; 2017 Feb; 14(2):229-243. PubMed ID: 27402029
[TBL] [Abstract][Full Text] [Related]
38. Dual pH/reduction-responsive hybrid polymeric micelles for targeted chemo-photothermal combination therapy.
Zhang L; Qin Y; Zhang Z; Fan F; Huang C; Lu L; Wang H; Jin X; Zhao H; Kong D; Wang C; Sun H; Leng X; Zhu D
Acta Biomater; 2018 Jul; 75():371-385. PubMed ID: 29777957
[TBL] [Abstract][Full Text] [Related]
39. Targeted nanomedicine for cancer therapeutics: Towards precision medicine overcoming drug resistance.
Bar-Zeev M; Livney YD; Assaraf YG
Drug Resist Updat; 2017 Mar; 31():15-30. PubMed ID: 28867241
[TBL] [Abstract][Full Text] [Related]
40. Functional block copolymer assemblies responsive to tumor and intracellular microenvironments for site-specific drug delivery and enhanced imaging performance.
Ge Z; Liu S
Chem Soc Rev; 2013 Sep; 42(17):7289-325. PubMed ID: 23549663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
